Dr Antonio Mirabueno Del Rosario Iii, MD | |
22 Bramhall St, Portland, ME 04102 | |
(207) 662-2526 | |
Not Available |
Full Name | Dr Antonio Mirabueno Del Rosario Iii |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 16 Years |
Location | 22 Bramhall St, Portland, Maine |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669748315 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD22177 (Maine) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Southern Maine Health Care | Biddeford, ME | Hospital |
Northern Light Mercy Hospital | Portland, ME | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Spectrum Healthcare Partners Pa | 7618871245 | 265 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today that it had received a Notice of Allowance from the United States Patent and Trademark Office for claims related to the use of mir-205 as a diagnostic in lung cancer.
A new white paper from The Gerontological Society of America (GSA) highlights the variety of challenges that persons with dementia-related psychosis and their caregivers have encountered during moves through different health care settings - and proposes strategies to address these challenges.
A minimally invasive procedure to determine whether patients with drug-resistant epilepsy are candidates for brain surgery is safer, more efficient, and leads to better outcomes than the traditional method, according to new research by The University of Texas Health Science Center at Houston.
Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.
Computer and web-based weight management programmes may provide a cost effective way of addressing the growing problem of obesity, according to a team of seven researchers who undertook a Cochrane systematic review.
› Verified 3 days ago
Entity Name | Spectrum Healthcare Partners Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245252212 PECOS PAC ID: 7618871245 Enrollment ID: O20040127000198 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today that it had received a Notice of Allowance from the United States Patent and Trademark Office for claims related to the use of mir-205 as a diagnostic in lung cancer.
A new white paper from The Gerontological Society of America (GSA) highlights the variety of challenges that persons with dementia-related psychosis and their caregivers have encountered during moves through different health care settings - and proposes strategies to address these challenges.
A minimally invasive procedure to determine whether patients with drug-resistant epilepsy are candidates for brain surgery is safer, more efficient, and leads to better outcomes than the traditional method, according to new research by The University of Texas Health Science Center at Houston.
Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.
Computer and web-based weight management programmes may provide a cost effective way of addressing the growing problem of obesity, according to a team of seven researchers who undertook a Cochrane systematic review.
› Verified 3 days ago
Entity Name | Mainehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today that it had received a Notice of Allowance from the United States Patent and Trademark Office for claims related to the use of mir-205 as a diagnostic in lung cancer.
A new white paper from The Gerontological Society of America (GSA) highlights the variety of challenges that persons with dementia-related psychosis and their caregivers have encountered during moves through different health care settings - and proposes strategies to address these challenges.
A minimally invasive procedure to determine whether patients with drug-resistant epilepsy are candidates for brain surgery is safer, more efficient, and leads to better outcomes than the traditional method, according to new research by The University of Texas Health Science Center at Houston.
Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.
Computer and web-based weight management programmes may provide a cost effective way of addressing the growing problem of obesity, according to a team of seven researchers who undertook a Cochrane systematic review.
› Verified 3 days ago
Entity Name | Spectrum Healthcare Partners Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245252212 PECOS PAC ID: 7618871245 Enrollment ID: O20040915000845 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today that it had received a Notice of Allowance from the United States Patent and Trademark Office for claims related to the use of mir-205 as a diagnostic in lung cancer.
A new white paper from The Gerontological Society of America (GSA) highlights the variety of challenges that persons with dementia-related psychosis and their caregivers have encountered during moves through different health care settings - and proposes strategies to address these challenges.
A minimally invasive procedure to determine whether patients with drug-resistant epilepsy are candidates for brain surgery is safer, more efficient, and leads to better outcomes than the traditional method, according to new research by The University of Texas Health Science Center at Houston.
Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.
Computer and web-based weight management programmes may provide a cost effective way of addressing the growing problem of obesity, according to a team of seven researchers who undertook a Cochrane systematic review.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Antonio Mirabueno Del Rosario Iii, MD 324 Gannett Dr Ste 200, South Portland, ME 04106-3266 Ph: (207) 482-7800 | Dr Antonio Mirabueno Del Rosario Iii, MD 22 Bramhall St, Portland, ME 04102 Ph: (207) 662-2526 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today that it had received a Notice of Allowance from the United States Patent and Trademark Office for claims related to the use of mir-205 as a diagnostic in lung cancer.
A new white paper from The Gerontological Society of America (GSA) highlights the variety of challenges that persons with dementia-related psychosis and their caregivers have encountered during moves through different health care settings - and proposes strategies to address these challenges.
A minimally invasive procedure to determine whether patients with drug-resistant epilepsy are candidates for brain surgery is safer, more efficient, and leads to better outcomes than the traditional method, according to new research by The University of Texas Health Science Center at Houston.
Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.
Computer and web-based weight management programmes may provide a cost effective way of addressing the growing problem of obesity, according to a team of seven researchers who undertook a Cochrane systematic review.
› Verified 3 days ago
David Edward Landry, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 | |
Francis Altman, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 144 State St, Anesthesia Department, Portland, ME 04101 Phone: 207-879-3385 | |
Dylan Wingfield, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-478-6024 | |
Dr. Frederick Craig Littlejohn, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1945 Congress St Ste 103, Portland, ME 04102 Phone: 207-835-8116 | |
Christopher James Beeler, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 | |
Charles F Adams, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 | |
Jeffrey Morse, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 144 State St, Anesthesia Department, Portland, ME 04101 Phone: 207-879-3385 |